logo
Select company
Select metric
$ -91.36MConsolidated Income
VS
Market
13
Sector
25
Industry
33
History
9
$ 45.78Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -91.36M
3/31/2025$ -87.41M
12/31/2024$ -83.58M
9/30/2024$ -101.6M
6/30/2024$ -92.22M
3/31/2024$ -81.19M
12/31/2023$ -81.17M
9/30/2023$ -59.31M
6/30/2023$ -67.25M
3/31/2023$ -77.74M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -21.77M.
  • Over the past 5 years, KORRO BIO INC's average Cons. Inc. has been $ -73.56M.
  • The median Cons. Inc. for KORRO BIO INC during this period was $ -81.38M
  • KORRO BIO INC reached its highest Cons. Inc. over the past 5 years at $ -21.77M.
  • The lowest Cons. Inc. recorded by KORRO BIO INC in the same timeframe $ -101.6M

KORRO BIO INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CRBU : CARIBOU BIOSCIENCES INC $ -164.26MACOG : ALPHA COGNITION INC $ -20.01MTCRX : TSCAN THERAPEUTICS INC $ -136.78MTVRD : TVARDI THERAPEUTICS INC $ -20.89MOBIO : ORCHESTRA BIOMED HOLDINGS INC $ -69.7MFATE : FATE THERAPEUTICS INC $ -171.52MCRVO : CERVOMED INC $ -22.61MOVID : OVID THERAPEUTICS INC $ -38.18MCBUS : CIBUS INC $ -303.21MARMP : ARMATA PHARMACEUTICALS INC $ -25.71M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

KRRO - Consolidated Income, Last 5 years

$ -101.6M

Minimum

Sep 30, 2024

$ -21.77M

Maximum

Sep 30, 2020

$ -73.56M

Average

$ -81.38M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M